It's a far more remarkable claim that $100B would improve production capacity, since that's a tiny tiny fraction of the costs of delay.

But if you think that producers are intentionally holding back, and don't understand mRNA vaccine differences from adenovirus vaccines that have been used forever, this might help:

https://blogs.sciencemag.org/pipeline/archives/2021/02/02/my...